
Tulixone TZ 1000mg/125mg Injection
Marketer
Tulip Lab Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Tulixone TZ 1000mg/125mg Injection
Azithromycin/Amoxicillin 1000mg/125mg injection is a dual-action antibiotic indicated for diverse bacterial infections. This medication combats microbial proliferation, curbing infection spread. Administration must be strictly under a physician's guidance. Consistent adherence to the prescribed dosage schedule is crucial; completing the full course, even with symptom improvement, is essential. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects warrant immediate medical attention. Allergic reactions (skin rashes, itching, swelling, respiratory distress) necessitate prompt emergency care. Prior to commencing treatment, disclose all current medications and pre-existing health conditions to your doctor. Pregnant or lactating individuals require specific medical counsel. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing somnolence or dizziness. Adequate rest, nutrition, and hydration are recommended for optimal recovery. Your physician may order laboratory tests to monitor therapeutic response.
Uses of Tulixone TZ 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Tulixone TZ 1000mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Tulixone TZ 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Tulixone TZ 1000mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Tulixone TZ 1000mg/125mg Injection works:
Each vial of Tulixone TZ 1000 mg/125 mg Injection contains ceftriaxone, a broad-spectrum antibiotic, and tazobactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, thereby hindering bacterial growth. Tazobactam's role is to counteract bacterial enzymes that would otherwise inactivate ceftriaxone, thus optimizing its antimicrobial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Tulixone TZ 1000 mg/125 mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Tulixone TZ (1000 mg/125 mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nonetheless, data from human studies are scarce.
Breast feedingCAUTION
Administering Tulixone TZ 1000 mg/125 mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Tulixone TZ 1000 mg/125 mg Injection can lead to reduced attentiveness, visual impairment, drowsiness, and dizziness. Driving is prohibited if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Tulixone TZ 1000 mg/125 mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Tulixone TZ 1000 mg/125 mg Injection requires careful consideration in individuals with significant hepatic impairment. Dosage modification for Tulixone TZ 1000 mg/125 mg Injection may be necessary. Physician consultation is advised. Altering the Tulixone TZ 1000 mg/125 mg Injection dosage is not suggested for patients experiencing mild to moderate liver dysfunction.
What if you forget to take Tulixone TZ 1000mg/125mg Injection :
Omitting a scheduled dose of Tulixone TZ 1000 mg/125 mg Injection requires immediate physician consultation.
Facts to Know About Tulixone TZ 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
